Why the study?
Chronic heart failure carries high morbidity and mortality in the elderly, where age-related cardiovascular changes represent an independent risk factor requiring effective drug treatment.
This article reviews the recent progress in drug therapy aimed at improving clinical symptoms, quality of life, and reducing hospitalization and mortality in older patients with chronic heart failure.
May guide older HF management; leaves open optimal regimens pending dedicated trials.
Chronic heart failure(CHF) is a serious public health problem in the world, which occurs mostly in the elderly,with extremely high morbidity and mortality. The physiological changes in the cardiovascular system caused by aging are an independent risk factor for CHF. For this reason, effective drug treatment is often used to improve the clinical symptoms and quality of life of older CHF patients, and ultimately achieve the goal of reducing hospitalization rate and cardiovascular mortality. This article describes recent progress of drug therapy for older patients in chronic heart failure.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: